6929260
Last Update Posted: 2025-04-16
Recruiting has not begun
All Genders accepted | 18 Years-65 Years |
20 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z
The study aims to assess the effect of ceralasertib on the pharmacokinetics (PK) of Drug X, Drug Y and Drug Z in participants with advanced solid tumours.
Eligibility
Relevant conditions:
Advanced Solid Tumours
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov